Fitbit Flex
Fitbit Flex is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
0
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Incentivizing Lifestyle Modification to Reduce Disease Burden
Long-Term Effects of Torso-Weighting
Exercise, Activity and Smoking in Young Adults
A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients
Clinical Trials (4)
Incentivizing Lifestyle Modification to Reduce Disease Burden
Long-Term Effects of Torso-Weighting
Exercise, Activity and Smoking in Young Adults
A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients
All 4 trials loaded
Drug Details
- Intervention Type
- Device
- Total Trials
- 4